Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 3/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | ATM | Q13315 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | RAB9A | P51151 | 2/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | CASP7 | P55210 | 1/20 | 0.31 |
| ▸ | HBB | P68871 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | BCHE | P06276 | 2/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2254290 | 0.90 | NPC1 (0.37) | CYP2A6CYP1A2ATMMEN1KMT2A | |
| SCHEMBL4584794 | 0.88 | TLR8 (0.38) | CYP2A6CYP1A2ATMMEN1KMT2A | |
| SCHEMBL2256644 | 0.87 | KCNH2 (0.39) | ATMMEN1KMT2ARAB9ANPC1 | |
| SCHEMBL2252881 | 0.87 | KCNH2 (0.39) | ATMMEN1KMT2ARAB9ANPC1 | |
| SCHEMBL4585267 | 0.87 | KCNH2 (0.39) | ATMMEN1KMT2ARAB9ANPC1 | |
| SCHEMBL6439117 | 0.87 | KCNH2 (0.39) | ATMMEN1KMT2ARAB9ANPC1 | |
| SCHEMBL4584285 | 0.87 | KCNH2 (0.39) | ATMMEN1KMT2ARAB9ANPC1 | |
| SCHEMBL4585268 | 0.87 | KCNH2 (0.39) | ATMMEN1KMT2ARAB9ANPC1 | |
| SCHEMBL4585792 | 0.87 | KCNH2 (0.39) | ATMMEN1KMT2ARAB9ANPC1 | |
| SCHEMBL718453 | 0.85 | CYP2A6 (0.44) | CYP2A6CYP1A2ATMMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8334391-B2 | Functionalized heteroacenes | XEROX CORPORATION (US) | 2012-12-18 | — | — | US | claimed |
| US-7372071-B2 | Functionalized heteroacenes and electronic devices generated therefrom | XEROX CORPORATION (US) | 2008-05-13 | — | — | US | claimed |
| US-20070260069-A1 | Functionalized heteroacenes | XEROX CORPORATION | 2007-11-08 | — | — | US | claimed |
| US-20070235721-A1 | Functionalized heteroacenes and electronic devices generated therefrom | XEROX CORPORATION | 2007-10-11 | — | — | US | claimed |
| US-RE31300-E | Process for preparing alkyl- or arylphosphonothioic dihalides | STAUFFER CHEMICAL COMPANY (US) | 1983-07-05 | — | — | US | claimed |
| US-4130583-A | AUTOGENOUS PRESSURE | STAUFFER CHEMICAL COMPANY (US) | 1978-12-19 | — | — | US | claimed |
| US-4052463-A | PROCESS FOR PREPARING TERTIARY PHOSPHINE SULFIDES AND OXIDES | STAUFFER CHEMICAL COMPANY (US) | 1977-10-04 | — | — | US | claimed |
| US-4000190-A | FROM DIALKYL OR DIARYL DISULFIDES, PHOSPHORUS, AND PHOSPHORUS TRIHALIDE | STAUFFER CHEMICAL COMPANY (US) | 1976-12-28 | — | — | US | claimed |
| US-3968156-A | Process for preparing alkyl-or arylphosphonothioic dihalides | STAUFFER CHEMICAL COMPANY (US) | 1976-07-06 | — | — | US | claimed |
| US-3962323-A | PHOSPHORUS TRIHALIDE | STAUFFER CHEMICAL COMPANY (US) | 1976-06-08 | — | — | US | claimed |
| US-20220069354-A1 | SULFUR-BASED ELECTROLYTE SOLUTION FOR MAGNESIUM CELL | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2022-03-03 | — | — | US | disclosed |
| EP-3904337-A1 | SULFUR-BASED ELECTROLYTE SOLUTION FOR MAGNESIUM CELL | FUJIFILM Wako Pure Chemical Corporation (JP) | 2021-11-03 | — | — | EP | disclosed |
| EP-3439097-B1 | ELECTROLYTE SOLUTION CONTAINING MAGNESIUM IONS | FUJIFILM WAKO PURE CHEMICAL CORP (JP) | 2020-12-30 | — | — | EP | disclosed |
| US-10727534-B2 | Electrolyte solution containing magnesium ions | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2020-07-28 | — | — | US | disclosed |
| WO-2020138377-A1 | SULFUR-BASED ELECTROLYTE SOLUTION FOR MAGNESIUM CELL | 富士フイルム和光純薬株式会社 | 2020-07-02 | — | — | WO | disclosed |
| US-4076746-A | FROM AN ALKYL OR ARYL HALIDE AND PHOSPHORUS SESQUISULFIDE | STAUFFER CHEMICAL COMPANY (US) | 1978-02-28 | — | — | US | disclosed |
| US-4052463-A | PROCESS FOR PREPARING TERTIARY PHOSPHINE SULFIDES AND OXIDES | STAUFFER CHEMICAL COMPANY (US) | 1977-10-04 | — | — | US | disclosed |
| US-4000190-A | FROM DIALKYL OR DIARYL DISULFIDES, PHOSPHORUS, AND PHOSPHORUS TRIHALIDE | STAUFFER CHEMICAL COMPANY (US) | 1976-12-28 | — | — | US | disclosed |
| US-3968156-A | Process for preparing alkyl-or arylphosphonothioic dihalides | STAUFFER CHEMICAL COMPANY (US) | 1976-07-06 | — | — | US | disclosed |
| US-3962323-A | PHOSPHORUS TRIHALIDE | STAUFFER CHEMICAL COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10727534-B2 | Electrolyte solution containing magnesium ions | MLX, PRDX1, PRDX6 | CYP2A6 389/4885CYP1A2 815/4885ATM 3775/4885 |
| US-20070260069-A1 | Functionalized heteroacenes | SOD1, AHR, NR0B2 | CYP2A6 2722/4885CYP1A2 703/4885ATM 3265/4885 |
| US-20220069354-A1 | SULFUR-BASED ELECTROLYTE SOLUTION FOR MAGNESIUM CELL | SLC26A3, PRDX4, PRDX2 | CYP2A6 1852/4885CYP1A2 3884/4885ATM 4487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.